MTD vs DGX — Key Metrics

Metric MTD (METTLER TOLEDO INTERNATIONAL INC) DGX (QUEST DIAGNOSTICS INC)
Price1737.26259.69
Market Cap34.55 Billion28.57 Billion
P/E (TTM)37.6325.51
P/B (Quarterly)441.0743.487
P/S (TTM)8.232.41
Net Profit Margin (TTM)22.29.5
Gross Margin (TTM)60.433.1
ROE (TTM)14966.115.2
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

METTLER TOLEDO INTERNATIONAL INC
vs
 
QUEST DIAGNOSTICS INC
 
METTLER TOLEDO INTERNATIONAL INC
vs
 
QUEST DIAGNOSTICS INC
Performance Comparison
AI Model Recommendation
MTD · METTLER TOLEDO INTERNATIONAL INC

Greatly Underperform

-84
UnderperformOutperform
DGX · QUEST DIAGNOSTICS INC

Underperform

-8
UnderperformOutperform
Recommendation Summary

Stock MTD is projected to greatly underperform the market, stock DGX is projected to underperform the market. Upfront Recommendation: DGX.

Financial Metrics
Prices delayed ~15 min
MTD Metrics DGX
$1,737.26 Price $259.69
— Market Capitalization —
37.63 Price to Earnings Ratio 25.51
8.23 Price to Sales 2.41
39.69 Price to FCF Ratio 20.78
13.63 Price to Gross Profit 7.29
25.11 Price to Current Assets 9.17

MTD vs DGX at a glance

Mettler Toledo International INC (MTD) and Quest Diagnostics INC (DGX) are both Diagnostics & Research companies in the Healthcare sector. MTD is the larger, at $34.6 billion in market value against $28.6 billion for DGX, about 1.2 times the size.

On trailing-twelve-month figures, MTD trades at 37.6 times trailing earnings and DGX at 25.5; net profit margins are 22.2% and 9.5%.

The Upfront Investment model currently rates MTD Greatly Underperform and DGX Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.